CORTICOSTEROID THERAPY
CORTICOSTEROID THERAPY Lloyd Axelrod This chapter examines the risks associated with the use of glucocorticoids and of mineralocorticoids for various illnesses, and provides guidelines for the administration of these commonly…
CORTICOSTEROID THERAPY Lloyd Axelrod This chapter examines the risks associated with the use of glucocorticoids and of mineralocorticoids for various illnesses, and provides guidelines for the administration of these commonly…
CONCLUSION Part of “CHAPTER 77 – CONGENITAL ADRENAL HYPERPLASIA“ Related posts: DEFINITIONS THYROID-HORMONE RECEPTOR BINDING TO THYROID HORMONE RESPONSE ELEMENTS DISEASE-SPECIFIC VARIATION RADIATION AND THYROID CARCINOMA PHYSICAL EXAMINATION AND MENSURATION…
OTHER GENETIC DISORDERS RELATED TO CONGENITAL ADRENAL HYPERPLASIA Part of “CHAPTER 77 – CONGENITAL ADRENAL HYPERPLASIA“ Several other disorders involve adrenal steroid-synthesizing enzymes. Strictly speaking, the CMO deficiencies and other…
CLINICAL FEATURES Part of “CHAPTER 77 – CONGENITAL ADRENAL HYPERPLASIA“ 21-HYDROXYLASE (P450C21) DEFICIENCY Patients with this commonly diagnosed enzyme deficiency cannot adequately synthesize cortisol. Insufficient cortisol synthesis results in overproduction…
EMBRYOLOGY Part of “CHAPTER 77 – CONGENITAL ADRENAL HYPERPLASIA“ The fetal gonads remain undifferentiated until about the seventh week of gestation (see Chap. 90). At that time, in normal 46,XY…
CONGENITAL ADRENAL HYPERPLASIA Phyllis W. Speiser Congenital adrenal hyperplasia (CAH) is a group of inherited diseases caused by defective activity in one of five enzymes that contribute to the synthesis…